|
|
|
(March 18, 2025) – Today, the Senate Financial Institutions and Insurance Committee took action to amend SB 284, to take out the pharmaceutical manufacturer wholesalers.
|
|
|
|
|
|
(March 18, 2025) – Today, the Senate Public Health and Welfare Committee held a hearing on HB 2217 and worked HB 2039, HB 2311 and HB 2335.
|
|
|
|
|
|
(March 18, 2025) – Today, the House and Senate took final action votes and debated bills before them.
|
|
|
|
|
|
(March 17, 2025) – Today, the Senate Financial Institutions and Insurance Committee held a hearing on Senate Bill 284, the legislation would ensure that drug manufacturers cannot limit contract pharmacies or ask for additional data from 340B entities than other contracted locations.
|
|
|
|
|
|
(March 17, 2025) – Today, the Senate Ways and Means Committee held hearings on HB 2195, HB 2221, SB 290 and SCR 1612.
|
|
|
|
|
|
(March 17, 2025) – Today, the full House took final votes on SB 194, SB 27, SB 28, SB 32, SB 42, SB 139 and SB 166. The House debated SB 50, SB 78, HB 2402, SB 114, and Sub for HB 2012.
|
|
|
|
|
|
(March 17, 2025) – Today, the Senate Federal and State Affairs Committee narrowly voted down SB 196.
|
|
|
|
|
|
(March 17, 2025) – Today, the Senate is slated to debate HB 2333, HB 2044, HB 2049, HB 2201, SB 119 HB 2061, HB 2061, HB 2371, HB 2075, HB 2168 and HB 2030.
|
|
|
|
|
|
(March 17, 2025) – This week, committees will finalize work before them on Monday and Tuesday. The House and Senate will be working on bills on the respective chamber floors all day starting Wednesday. Additionally, conference committees will be meeting to begin to package bills together and come up with final agreements.
|
|
|
|
|
|
(March 17, 2025) – SB 291, SB 294, SB 295, HB 2405, HCR 5013
|
|
|